Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 6 (2009), Issue 3 (March)

1. Intramolecular axial ligation of zinc porphyrin cores with triazole links within dendrimers.
   Chemistry, 15(11): 2617-24. [Abstract] [Full-text]
2. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
   J Clin Oncol, 27(7): 1007-13. [Abstract] [Full-text]
3. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
   J Clin Oncol, 27(7): 1014-9. [Abstract] [Full-text]
4. Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.
   J Clin Oncol, 27(7): 1122-9. [Abstract] [Full-text]
5. Blood pleurodesis for the medical management of pneumothorax.
   Thorax, 64(3): 258-60. [Abstract] [Full-text]
6. Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era.
   J Med Virol, 81(4): 578-81. [Abstract] [Full-text]
7. Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.
   Pediatr Infect Dis J, 28(3): 246-8. [Abstract] [Full-text]
8. Preventing bladder tumor implantation with photodynamic therapy in a rat model mimicking post-fluorescence guided transurethral resection.
   J Urol, 181(3): 1381-6. [Abstract] [Full-text]
9. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
   Cancer Sci, 100(3): 546-51. [Abstract] [Full-text]
10. Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency.
    J Am Med Inform Assoc, 16(2): 203-10. [Abstract] [Full-text]
11. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
    Cancer Sci, 100(3): 369-74. [Abstract] [Full-text]
12. Structured product labeling improves detection of drug-intolerance issues.
    J Am Med Inform Assoc, 16(2): 211-9. [Abstract] [Full-text]
13. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Eur J Vasc Endovasc Surg, 37(3): 343-8. [Abstract] [Full-text]
14. Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherapy.
    Int J Radiat Oncol Biol Phys, 73(4): 1116-20. [Abstract] [Full-text]
15. Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.
    Biomaterials, 30(12): 2302-18. [Abstract] [Full-text]
16. Estimating the impact of the discontinuation of medical interventions on health outcomes.
    Am J Epidemiol, 169(6): 653-6. [Abstract] [Full-text]
17. Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study.
    Am J Hematol, 84(3): 161-6. [Abstract] [Full-text]
18. Treatment of canine osseous tumors with photodynamic therapy: a pilot study.
    Clin Orthop Relat Res, 467(4): 1028-34. [Abstract] [Full-text]
19. "Natural history" of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Eur J Surg Oncol, 35(4): 434-8. [Abstract] [Full-text]
20. Minimizing misclassification of hormone users at mammography screening.
    Int J Cancer, 124(9): 2159-65. [Abstract] [Full-text]
21. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.
    Biomaterials, 30(13): 2440-8. [Abstract] [Full-text]
22. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.
    Br J Cancer, 100(5): 758-63. [Abstract] [Full-text]
23. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
    Br J Cancer, 100(5): 732-8. [Abstract] [Full-text]
24. Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer.
    Br J Cancer, 100(5): 707-12. [Abstract] [Full-text]
25. Pattern of cancer risk in persons with AIDS in Italy in the HAART era.
    Br J Cancer, 100(5): 840-7. [Abstract] [Full-text]
26. Fluids and nutrition: perspectives from Jewish Law (Halachah).
    South Med J, 102(3): 248-50. [Abstract] [Full-text]
27. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
    Lancet Oncol, 10(3): 247-57. [Abstract] [Full-text]
28. Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort.
    Clin Infect Dis, 48(7): 988-91. [Abstract] [Full-text]
29. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Ophthalmology, 116(3): 544-551.e1. [Abstract] [Full-text]
30. Leg ulcer treatment.
    J Vasc Surg, 49(3): 804-8. [Abstract] [Full-text]
31. Successful pregnancy after treatment for ovarian malignant teratoma with growing teratoma syndrome.
    Fertil Steril, 91(3): 936.e1-3. [Abstract] [Full-text]
32. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature.
    Fertil Steril, 91(3): 930.e7-11. [Abstract] [Full-text]
33. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
    Fertil Steril, 91(3): 694-7. [Abstract] [Full-text]
34. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.
    J Clin Oncol, 27(8): 1168-76. [Abstract] [Full-text]
35. Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
    J Clin Oncol, 27(8): 1177-83. [Abstract] [Full-text]
36. Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
    J Clin Oncol, 27(8): 1262-7. [Abstract] [Full-text]
37. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
    J Clin Oncol, 27(8): 1227-34. [Abstract] [Full-text]
38. Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.
    J Clin Oncol, 27(8): 1257-61. [Abstract] [Full-text]
39. Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
    J Clin Oncol, 27(8): 1290-6. [Abstract] [Full-text]
40. Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91.
    J Clin Oncol, 27(8): 1297-303. [Abstract] [Full-text]
41. Preoperative statin use and infection after cardiac surgery: a cohort study.
    Clin Infect Dis, 48(7): e66-72. [Abstract] [Full-text]
42. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.
    Clin Infect Dis, 48(7): 940-50. [Abstract] [Full-text]
43. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.
    Clin Infect Dis, 48(7): 856-62. [Abstract] [Full-text]
44. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Toxicol Lett, 186(1): 45-51. [Abstract] [Full-text]
45. Effects of progesterone on male-mediated infant-directed aggression.
    Behav Brain Res, 199(2): 340-4. [Abstract] [Full-text]
46. Microinjection of zebrafish embryos to analyze gene function.
    J Vis Exp. [Abstract] [Full-text]
47. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
    Arch Ophthalmol, 127(3): 282-90. [Abstract] [Full-text]
48. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
    Int J Antimicrob Agents, 33(4): 354-9. [Abstract] [Full-text]
49. In vivo (1)H MRS of WSU-DLCL2 human non-Hodgkin's lymphoma xenografts: response to rituximab and rituximab plus CHOP.
    NMR Biomed, 22(3): 259-65. [Abstract] [Full-text]
50. Effects of different fluid resuscitation speeds on blood glucose and interleukin-1 beta in hemorrhagic shock.
    J Trauma, 66(3): 683-92. [Abstract] [Full-text]
51. Adjuvant therapy for colon cancer: present and perspectives.
    Cancer Treat Rev, 35(2): 160-6. [Abstract] [Full-text]
52. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
    J Am Geriatr Soc, 57(3): 403-11. [Abstract] [Full-text]
53. Prescription patterns of antimicrobials in veterinary practices in Switzerland.
    J Antimicrob Chemother, 63(4): 805-11. [Abstract] [Full-text]
54. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration.
    Biomaterials, 30(14): 2816-25. [Abstract] [Full-text]
55. In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.
    BMC Biotechnol, 9: 8. [Abstract] [Full-text]
56. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation.
    Circ Res, 104(5): 679-87. [Abstract] [Full-text]
57. HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study.
    Neurology, 72(11): 992-8. [Abstract] [Full-text]
58. A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
    Clin Cancer Res, 15(6): 2158-65. [Abstract] [Full-text]
59. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
    Clin Cancer Res, 15(6): 2107-15. [Abstract] [Full-text]
60. Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.
    Clin Cancer Res, 15(6): 1973-80. [Abstract] [Full-text]
61. The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP).
    Heart, 95(7): 559-63. [Abstract] [Full-text]
62. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery.
    Br J Surg, 96(4): 331-41. [Abstract] [Full-text]
63. A survey of inhalant use disorders among delinquent youth: prevalence, clinical features, and latent structure of DSM-IV diagnostic criteria.
    BMC Psychiatry, 9: 8. [Abstract] [Full-text]
64. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.
    Br J Cancer, 100(6): 881-7. [Abstract] [Full-text]
65. Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate.
    Ann Hematol, 88(5): 433-9. [Abstract] [Full-text]
66. Oxovanadium(IV)-based near-IR PDT agents: design to biological evaluation.
    Chem Commun (Camb). [Abstract] [Full-text]
67. Synthesis of calixarene-capped carbosilane dendrimers.
    J Org Chem, 74(6): 2527-32. [Abstract] [Full-text]
68. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    J Clin Oncol, 27(9): 1446-55. [Abstract] [Full-text]
69. Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
    J Clin Oncol, 27(9): 1405-12. [Abstract] [Full-text]
70. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    J Clin Oncol, 27(9): 1413-8. [Abstract] [Full-text]
71. Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.
    J Clin Oncol, 27(9): 1432-9. [Abstract] [Full-text]
72. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
    J Clin Oncol, 27(9): 1419-25. [Abstract] [Full-text]
73. Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.
    J Clin Oncol, 27(9): 1456-61. [Abstract] [Full-text]
74. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    J Clin Oncol, 27(9): 1368-74. [Abstract] [Full-text]
75. Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer.
    J Clin Oncol, 27(9): 1401-4. [Abstract] [Full-text]
76. A systematic review of randomized controlled trials that evaluate strategies to avoid epidural vein cannulation during obstetric epidural catheter placement.
    Anesth Analg, 108(4): 1232-42. [Abstract] [Full-text]
77. Fluid flow through intravenous cannulae in a clinical model.
    Anesth Analg, 108(4): 1198-202. [Abstract] [Full-text]
78. Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.
    J Immunol, 182(7): 4328-38. [Abstract] [Full-text]
79. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells.
    PLoS ONE, 4(3): e4903. [Abstract] [Full-text]
80. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.
    J Acquir Immune Defic Syndr, 50(5): 529-36. [Abstract] [Full-text]
81. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines.
    Hypertension, 53(4): 617-23. [Abstract] [Full-text]
82. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    J Surg Oncol, 99(5): 302-6. [Abstract] [Full-text]
83. A novel interventional radiology technique for arterial infusion chemotherapy against advanced pancreatic cancer.
    AJR Am J Roentgenol, 192(4): W168-77. [Abstract] [Full-text]
84. Freehand real-time MRI-guided lumbar spinal injection procedures at 1.5 T: feasibility, accuracy, and safety.
    AJR Am J Roentgenol, 192(4): W161-7. [Abstract] [Full-text]
85. Association of Y chromosome haplogroup I with HIV progression, and HAART outcome.
    Hum Genet, 125(3): 281-94. [Abstract] [Full-text]
86. Infection rates following perioperative prophylactic antibiotics versus postoperative extended regimen prophylactic antibiotics in surgical management of mandibular fractures.
    J Oral Maxillofac Surg, 67(4): 827-32. [Abstract] [Full-text]
87. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
    Pediatr Blood Cancer, 52(5): 664-6. [Abstract] [Full-text]
88. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
    BJU Int, 103(7): 978-86. [Abstract] [Full-text]
89. Biodegradable luminescent porous silicon nanoparticles for in vivo applications.
    Nat Mater, 8(4): 331-6. [Abstract] [Full-text]
90. Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial.
    Gynecol Oncol, 113(1): 16-20. [Abstract] [Full-text]
91. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Gynecol Oncol, 113(1): 63-7. [Abstract] [Full-text]
92. Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
    Gynecol Oncol, 113(1): 57-62. [Abstract] [Full-text]
93. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Int J Radiat Oncol Biol Phys, 73(5): 1358-63. [Abstract] [Full-text]
94. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Int J Radiat Oncol Biol Phys, 73(5): 1335-42. [Abstract] [Full-text]
95. Resuscitation tables: a useful tool in calculating pre-burns unit fluid requirements.
    Emerg Med J, 26(4): 245-9. [Abstract] [Full-text]
96. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
    Clin Exp Dermatol, 34(3): 385-9. [Abstract] [Full-text]
97. Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold.
    Proc Natl Acad Sci U S A, 106(12): 4623-8. [Abstract] [Full-text]
98. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
    Jpn J Clin Oncol, 39(4): 237-43. [Abstract] [Full-text]
99. Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
    Oncology, 76(4): 275-85. [Abstract] [Full-text]
100. Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.
     Jpn J Clin Oncol, 39(4): 244-50. [Abstract] [Full-text]
101. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
     Jpn J Clin Oncol, 39(4): 225-30. [Abstract] [Full-text]
102. Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304.
     Jpn J Clin Oncol, 39(4): 271-3. [Abstract] [Full-text]
103. Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration.
     Br J Ophthalmol, 93(4): 468-73. [Abstract] [Full-text]
104. Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction.
     Br J Ophthalmol, 93(4): 541-4. [Abstract] [Full-text]
105. Evaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis.
     J Biomed Mater Res A, 89(2): 281-92. [Abstract] [Full-text]
106. Postponing medication administration.
     Am J Nurs, 109(4): 21-3. [Abstract] [Full-text]
107. A visual dosing aid for first-line pediatric antiretroviral treatment in resource-poor settings.
     J Trop Pediatr, 55(2): 135-7. [Abstract] [Full-text]
108. Efficacy of teicoplanin for the prevention of surgical site infections after total hip or knee arthroplasty: a prospective, open-label study.
     Int J Antimicrob Agents, 33(5): 437-40. [Abstract] [Full-text]
109. A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
     Cancer Chemother Pharmacol, 63(6): 1147-56. [Abstract] [Full-text]
110. Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
     Cancer Chemother Pharmacol, 63(6): 1161-3. [Abstract] [Full-text]
111. Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.
     Cancer Chemother Pharmacol, 63(6): 1111-9. [Abstract] [Full-text]
112. Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
     Cancer Chemother Pharmacol, 63(6): 1091-6. [Abstract] [Full-text]
113. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
     Cancer Chemother Pharmacol, 63(6): 1083-90. [Abstract] [Full-text]
114. Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
     Cancer Chemother Pharmacol, 63(6): 1065-71. [Abstract] [Full-text]
115. Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
     Cancer Chemother Pharmacol, 63(6): 1073-82. [Abstract] [Full-text]
116. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
     Cancer Chemother Pharmacol, 63(6): 1049-63. [Abstract] [Full-text]
117. Improvement of seminal parameters and pregnancy rates after antegrade sclerotherapy of internal spermatic veins.
     Fertil Steril, 91(4): 1085-9. [Abstract] [Full-text]
118. In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen.
     Prostate, 69(6): 585-94. [Abstract] [Full-text]
119. Nonstructured treatment interruptions among injection drug users in Baltimore, MD.
     J Acquir Immune Defic Syndr, 50(4): 360-6. [Abstract] [Full-text]
120. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
     Am Heart J, 157(4): 673-9.e1. [Abstract] [Full-text]
121. Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.
     Am Heart J, 157(4): 613-9. [Abstract] [Full-text]
122. Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome.
     Stroke, 40(4): 1522-5. [Abstract] [Full-text]

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.